Navigation Links
Echo Therapeutics Announces $3.6 Million Warrant Exercises
Date:1/4/2012

PHILADELPHIA, Jan. 4, 2012 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE) today announced that it has received warrant exercises generating a total of approximately $3.6 million in cash proceeds.  These warrant exercises bring the company's year-end cash balance to approximately $9.2 million.

"This cash infusion, following the recent positive clinical results for use of our Symphony System, represents important achievements for Echo as we progress toward regulatory clearance and commercialization," said Patrick T. Mooney, M.D., Chairman and CEO of Echo Therapeutics.  "We believe this additional capital strengthens the balance sheet and will provide greater flexibility in the accelerated product development and clinical validation of our products."

About Echo Therapeutics
Echo Therapeutics is developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system for patients with diabetes and for use in hospital critical care units.  Echo is also developing its needle-free Prelude® SkinPrep System as a platform technology for enhanced skin permeation for delivery of topical pharmaceuticals.

Cautionary Statement Regarding Forward Looking Statements

The statements in this press release that are not historical facts may constitute forward-looking statements that are based on current expectations and are subject to risks and uncertainties that could cause actual future results to differ materially from those expressed or implied by such statements. Those risks and uncertainties include, but are not limited to, risks related to regulatory approvals and the success of Echo's and its partners' ongoing studies, including the safety and efficacy of Echo's Symphony tCGM and Prelude SkinPrep Systems, the failure of future development and preliminary marketing efforts related to Echo's Symphony tCGM and Prelude SkinPrep Systems, Echo's ability
'/>"/>

SOURCE Echo Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Echo Therapeutics to Present at Biotech Showcase 2012 in San Francisco
2. Orexigen® Therapeutics Completes Public Offering of Common Stock and Warrants to Purchase Common Stock
3. AuraSense Therapeutics Secures Series B Equity Investment
4. PTC Therapeutics Antibacterial Program Receives $5 Million Award from the Wellcome Trust
5. Arecor Forms Collaboration With Lilly to Develop Advanced Formulations of Protein Therapeutics
6. Cerevast Therapeutics Receives CE Mark for Clotbust ER™ Ultrasound Stroke Treatment Device
7. Orexigen® Therapeutics Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common Stock
8. Regulus Therapeutics Initiates an Orphan and Rare Disease microRNA Therapeutic Effort in Brain Cancer
9. Cell Therapeutics, Inc. Announces Institutional Investors Purchase $20 Million of Preferred Stock and Warrants
10. Pearl Therapeutics Reports Positive Phase 2b Results of PT001 in Patients With COPD
11. Echo Therapeutics to Present at the Oppenheimer Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/256szd/corporate ... Reputation of Pharma in 2014 - a Perspective of ... to their offering. For the first time, ... corporate reputation of the pharmaceutical industry held by patient ... views of patient organisations representing all therapy areas. ...
(Date:4/17/2015)... -- Bionomics Limited (ASX:BNO, ADR:BMICY), a biopharmaceutical company focused ... the treatment of cancer and diseases of the central ... three of its most advanced oncology programs at the ... Annual Meeting being held from April 18-22, 2015 ... The presentation on the BNC105 program describes ...
(Date:4/16/2015)... Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ), a ... products for the treatment of central nervous system disorders, ... quarter of 2015 on Wednesday, May 6, 2015, after ... host a conference call at 4:30 PM ET on ... discuss the first quarter 2015 financial results and other ...
Breaking Medicine Technology:Corporate Reputation of Pharma in 2014 - The Perspective of Mental Health Patient Groups - 1st Edition 2Corporate Reputation of Pharma in 2014 - The Perspective of Mental Health Patient Groups - 1st Edition 3Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 2Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 3Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 4Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 5Vanda Pharmaceuticals to Announce First Quarter 2015 Financial Results on May 6, 2015 2
(Date:4/17/2015)... Enthusiasts of gourmet cuisine and beverages will ... 2015. The event will be held in the heart of ... Ave NW, Grand Rapids, MI 49503) and will feature wine ... Patrons are encouraged to savor the food and beverage pairings ... year’s event will feature seven chefs, including:, ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 Baptist Health ... have signed a partnership agreement designed to transform oncology ... The institutions have agreed to create a joint cancer ... protocols and translational research. Baptist MD Anderson Cancer Center ... providing a single destination for highly coordinated, multidisciplinary cancer ...
(Date:4/17/2015)... 17, 2015 Calvary Hospital recently announced Timothy ... Executive Vice President on May 11. The Fund directs all ... mission. Barr succeeds Vincent J. Spinelli, who retired several months ... take on and supervise the important work that the Fund ... “As Calvary continues to expand and bring our signature care ...
(Date:4/17/2015)... Nomedexamlifeinsurance.com has released a new blog post explaining how ... , Smoking is linked to numerous diseases like cancer ... smokers more money for life insurance plans. Someone who ... can qualify for advantageous offers. , The life ... non-smokers. Comparing quotes is the best method of reducing ...
(Date:4/17/2015)... Verndale, a Global Experience Technology Company, ... been chosen as a Boston Business Journal (BBJ) Pacesetter, ... the region. The BBJ’s Pacesetters represents privately held businesses ... 2014. This is the eighth consecutive year and the ... has been honored with this award. , “Being honored ...
Breaking Medicine News(10 mins):Health News:Children’s Leukemia Foundation of Michigan Presents 3rd Annual CRUSH Grand Rapids 2Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 2Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 3Health News:Timothy P. Barr Appointed Executive Vice President of Calvary Fund 2Health News:Timothy P. Barr Appointed Executive Vice President of Calvary Fund 3Health News:Life Insurance Quotes for Smokers Available Online 2Health News:Verndale Honored as 2015 Boston Business Journal Pacesetter, Named 46th Fastest Growing Private Company 2
... BioFit Engineered Products, an Ohio-based manufacturer and long-standing leader in ... and Atmospheric Administration (NOAA) with a solution to a unique ... habitat. , ... Bowling Green, OH ...
... expansion of its Sealy office. , ... Sealy, Texas (PRWEB) January 8, ... Sealy office. Located on Meyer Street the five-year old-practice has blossomed reaching ... of the surrounding communities as well., , , , ,The eye ...
... Service Employees,International Union (SEIU) announced the formation of the ... the patients that they serve,a greater voice as we ... nation,s,history. , Since adoption of ... made,numerous jurisdiction decisions that have helped members who do ...
... Internacional, S.A.B. de C.V. (BMV: LAB) ("Genomma Lab" ... and personal care products company announced that on January ... stock repurchase fund according to the terms approved by ... up to Ps. 100 million pesos. Company Description ...
... EXTON, Pa., Jan. 9 Kensey Nash Corporation (Nasdaq: ... release its earnings results for its second quarter ended ... Wednesday, January 28, 2009. Joe Kaufmann, President and ... results on Wednesday, January 28, 2009 at 9:00 A.M. ...
... study found, , , FRIDAY, Jan. 9 (HealthDay News) -- If ... cut your risk of dying from flu in half, research ... perfect match for the strains circulating in any given year, ... that included 10 flu seasons, worth of data also found ...
Cached Medicine News:Health News:BioFit 1Y Takes the Plunge to Fill Undersea Seating Role for NOAA 2Health News:Austin County Eye Expands Sealy Eye Clinic Office 2Health News:Statement From SEIU International President Andy Stern on UHW Leaders' Response to the Jurisdiction Decision 2Health News:Kensey Nash Corporation Announces Its Second Quarter 2009 Earnings Release Date and Teleconference 2Health News:You're Never Too Old for a Flu Shot 2Health News:You're Never Too Old for a Flu Shot 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: